Esomeprazole

Generic Details

Generic Name

Esomeprazole

Other Names

  • Nexium

Drug Class

  • Proton pump inhibitor

Chemical Formula

C17H19N3O3S

Molecular Weight

345.42 g/mol

Mechanism of Action

  • Inhibits the H+/K+ ATPase enzyme system in the gastric parietal cells, leading to a reduction in gastric acid secretion.

Indications

  • Gastroesophageal reflux disease (GERD)
  • Peptic ulcers
  • Helicobacter pylori eradication therapy
  • Zollinger-Ellison syndrome

Common Dosage Forms

  • Capsules
  • Tablets
  • Powder for oral suspension

Typical Dosage

  • 20-40 mg once daily for GERD

Pediatric Dosage

  • Safety and efficacy not established in children under 1 year old

Geriatric Dosage

  • No dosage adjustment necessary for elderly patients

Side Effects

  • Headache
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Vitamin B12 deficiency with long-term use

Contraindications

  • Hypersensitivity to esomeprazole or substituted benzimidazoles

Pregnancy Category

  • Category C - Risk cannot be ruled out

Lactation Safety

  • Compatible with breastfeeding, minimal risk expected

Drug Interactions

  • May interact with drugs that require gastric acid for absorption (e.g., ketoconazole, atazanavir)

Overdose Symptoms

  • Confusion
  • Drowsiness
  • Blurred vision
  • Dry mouth

Antidote for Overdose

  • No specific antidote, treatment is supportive

Storage Conditions

  • Store at room temperature (15-30°C)
  • Protect from light and moisture

Pharmacokinetics

  • Absorption: Rapidly absorbed from the gastrointestinal tract
  • Distribution: Protein binding is approximately 97%
  • Metabolism: Primarily hepatic via CYP2C19 and CYP3A4 enzymes
  • Excretion: Mainly excreted in the urine

Precautions

  • Monitor magnesium levels with long-term use
  • Avoid abrupt discontinuation to prevent rebound acid hypersecretion

Warnings

  • Increased risk of Clostridium difficile-associated diarrhea
  • Possible increased risk of bone fractures with long-term therapy

Others

  • May increase the risk of community-acquired pneumonia